Allogene Therapeutics, Inc. (ALLO)

2.265 -0.14 (-6.02%) USD  |  NASDAQ  |  Mar 27, 14:11
More

Allogene Therapeutics Operating Income (TTM)

Operating Income (TTM) Chart

View Operating Income (TTM) for ALLO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (TTM) Range, Past 5 Years

View Operating Income (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (TTM) Benchmarks

View Operating Income (TTM) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. Upgrade
Inovio Pharmaceuticals, Inc. Upgrade
Vaxart, Inc. Upgrade
Capricor Therapeutics, Inc. Upgrade
Agenus, Inc. Upgrade